778 hedge funds and large institutions have $9.9B invested in GSK in 2017 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 281 increasing their positions, 267 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
778
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$142M
Puts
$72.1M
Net Calls
Net Calls Change

Top Sellers

1 -$251M
2 -$85.5M
3 -$22.5M
4
Goldman Sachs
Goldman Sachs
New York
-$19.9M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$15.1M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.08B
2
$580M
3
$540M
4
$517M
5
$446M
6
$403M
7
$390M
8
$338M
9
$329M
10
$253M
11
$195M
12
$180M
13
$154M
14
$145M
15
$133M
16
$123M
17
$120M
18
$118M
19
$108M
20
$108M
21
$106M
22
$94.3M
23
$92.7M
24
$86.1M
25
$83.2M